EU Committee Approves New Food Applications for Martek's life'sDHA(TM)
COLUMBIA, Md., July 17 /PRNewswire-FirstCall/ -- DHA omega-3 innovator and maker of the life'sDHA(TM) brand of DHA, Martek Biosciences (Nasdaq: MATK ), announced today that it has received a unanimous positive vote from the Standing Committee On The Food Chain and Animal Health ...EU Committee Approves New Food Applications for Martek's life'sDHA™
life'sDHA Now Approved for Use in Bakery Products, All Dairy Products, Cereal Bars, Beverages Columbia, MD (Vocus) July 16, 2009 -- DHA omega-3 innovator and maker of the life'sDHA ™ brand of DHA, Martek Biosciences, announced today that it has received a unanimo...Photos: FDA Approves 12-Month Labeling Update for EVOLENCE(R) Collagen-Based Facial Filler
First and Only Collagen-Based Filler Proven To Last Through One Year HERZLIYA, Israel and SKILLMAN, N.J., June 8 /PRNewswire/ -- Ortho Dermatologics today announced that the U.S. Food and Drug Administration (FDA) approved a labeling supplement which includes efficacy and safety data through ...FDA Approves Boston Scientific's Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System
NATICK, Mass., May 27 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its TAXUS(R) Liberte (R) Atom(TM) Paclitaxel-Eluting Coronary Stent System, a highly deliverable, next-g...Arpida Annual General Meeting of Shareholders Approves All Board Proposals
REINACH, Switzerland, May 7 /PRNewswire-FirstCall/ -- The Annual General Meeting of Arpida Ltd (SIX: ARPN) has approved the proposals that were put forward by the Board of Directors. A total of 90 shareholders were present at the meeting that took place in Reinach today. 4,629,711 share...FDA Approves Label Change for Non-Invasive Fibroid Treatment
TIRAT CARMEL, Israel, April 7 /PRNewswire/ -- InSightec Ltd. announced today that the U.S. Food and Drug Administration (FDA) approved a label change for the company's ExAblate(R) 2000 MR-guided Focused Ultrasound (MRgFUS) system for the treatment of women with non-hysteroscopically resectable...FDA Approves SyntheMed's REPEL-CV(R) Adhesion Barrier for Use in Pediatric Cardiac Surgery
ISELIN, N.J., March 9 /PRNewswire-FirstCall/ -- SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion products, today announced that the U.S. Food and Drug Administration (FDA) has approved the Pre-market Approval (PMA)...FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD)
SYMBICORT provides a new, fast-acting(1) combination treatment option for millions of Americans with debilitating lung disease WILMINGTON, Del., Feb. 27 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN ) today announced that the U.S. Food and Drug Administration (FDA) has approved SYMBICO...FDA Approves Apidra(R) SoloSTAR(R) - a Prefilled Disposable Insulin Pen
- Apidra(R) SoloSTAR(R) is a Convenient Insulin Delivery Device to Help Patients with Diabetes Improve Glycemic Control BRIDGEWATER, N.J., Feb. 26 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that the U.S. Food and Drug Administration (FDA) approved Apidra(R) SoloSTAR(R) (insulin ...Encouraging high-risk research: DFG approves funding for 2 new Reinhart Koselleck projects
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has announced that it will fund two new especially innovative and high-risk research projects. The Joint Committee of Germany's largest research funding organisation, located in Bonn, has approved funding for two new Reinhart Ko...FDA Approves Clinical Studies of a Novel Anti-Cancer Drug Developed by Italian Researchers
NERVIANO, Italy, February 10 /PRNewswire/ -- - Nerviano Medical Sciences (NMS): Green Light From the FDA for the CDC7 Inhibitor Nerviano Medical Sciences (NMS) has secured Food and Drug Administration (FDA) approval to conduct for the first time clinical trials of a novel antitum...FDA Approves KAPIDEX(TM) (Dexlansoprazole) delayed release capsules for the Treatment of GERD
First proton pump inhibitor (PPI) with a Dual Delayed Release(TM) (DDR) formulation DEERFIELD, Ill., and OSAKA, Japan, Jan. 30 /PRNewswire/ -- Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today announced that the U.S. Food ...Bion Announces PENNVEST Board Approves $7.8 Million Financing for Kreider Farms Dairy Project
NEW YORK, Jan. 28 /PRNewswire-FirstCall/ -- Bion Environmental Technologies, Inc. (OTC Bulletin Board: BNET) announced today that on Monday, January 26, 2009, the Pennsylvania Infrastructure Investment Authority (PENNVEST) approved a $7.8 million loan to Bion PA 1, LLC (a wholly-owned subsidiary...Monsanto Board Approves 10 Percent Dividend Increase
ST. LOUIS, Jan. 14 /PRNewswire-FirstCall/ -- As the latest step in its ongoing commitment to return value to shareowners, Monsanto Company (NYSE: MON ) today announced that its Board of Directors declared a 10 percent increase in the quarterly dividend on its common shares from 24 cents per ...FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C
PLEASANTON, Calif., Dec. 31 /PRNewswire/ -- The United States Food & Drug Administration (FDA) today approved a new nucleic acid test from Roche to screen donated blood for HIV-1 Group M RNA, hepatitis C RNA and hepatitis B DNA in a single, automated assay. The test, called the cobas TaqSc...MultiVu Video Feed: U.S Food and Drug Administration (Fda) Approves Latisse(TM) --
First and Only Treatment Approved by the Fda For Hypotrichosis of Eyelashes The U.S. Food and Drug Administration (FDA) has approved LATISSE(TM) (bimatoprost ophthalmic solution) 0.03% as a novel treatment for hypotrichosis of the eyelashes. Eyelash hypotrichosis is another name for ha...FDA Approves Boston Scientific's Express(R) SD Renal Stent System
NATICK, Mass., Dec. 15 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced that the U.S. Food and Drug Administration (FDA) has approved the Express(R) SD Renal Monorail(R) Premounted Stent System for use as an adjunct to PTRA (percutaneous transluminal renal ang...AUDIO from Medialink and GlaxoSmithKline: FDA Approves Boostrix for Adults
NEW YORK, Dec. 11 /PRNewswire/ -- Many adults may be familiar with the tetanus and diphtheria booster shot they get from their healthcare providers. Here's more about a booster shot that protects adolescents and adults from whooping cough, in addition to those diseases. Listen to this repo...FDA Approves Boston Scientific's Apex(TM) PTCA Dilatation Catheter
New design provides more options for treating patients with complex lesions NATICK, Mass., Nov. 10 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced that it has received approval from the U.S. Food and Drug Administration to market its Apex(TM) PTCA(1) Dilatat...FDA Approves Duramed's LoSEASONIQUE(R) Oral Contraceptive
Duramed to Launch First Lower-Dose, Extended-Cycle Oral Contraceptive for the Prevention of Pregnancy MONTVALE, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL ) today announced that the U.S. Food and Drug Administration (FDA) has approved its subsidiary Durame...FDA Approves Orphan Drug Status for Revolutionary Cancer Drug for Children
LOS ANGELES, Oct. 20 /PRNewswire/ -- The Cure Our Children Foundation, a nonprofit charitable foundation dedicated to children, announced today that the U.S. Food and Drug Administration (FDA) has approved the Orphan Drug Designation of the foundation's unique drug product for children with Ew...FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania
WILMINGTON, Del., Oct. 10 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced that the U.S. Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR(R) (quetiapine fumarate) Extended-Release Tablets for the acute treatment of the depressive episodes associated with ...FDA Approves Fougera's Clotrimazole Cream USP 1%
MELVILLE, N.Y., Sept. 12 /PRNewswire/ -- Fougera, a division of Nycomed US Inc., today announced the FDA has approved its Clotrimazole Cream USP 1%. The generic formulation compares to Taro's Referenced Listed Drug (RLD) and is available in three sizes: 15g tubes (NDC # 0168-0133-15), 30g tube...Signalife Board Approves Merger
LOS ANGELES and LONDON, July 11 /PRNewswire-FirstCall/ -- Signalife, Inc. (Amex: SGN ) announced that it has received board approval to proceed with its previously-announced merger or similar business combination with Heart One Global Research, and that a specially-formed committee has been a...FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions
First Organ-specific MRI Contrast Agent Approved in the United States in More Than a Decade WAYNE, N.J., July 8 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc., a leader in diagnostic imaging, announced today that the U.S. Food and Drug Administration (FDA) has ...FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent
XIENCE V, Only Drug Eluting Stent to Demonstrate Superiority Over Market-Leading Stent in Clinical Trials, Now Available in United States for Treatment of Coronary Artery Disease ABBOTT PARK, Ill., July 2 /PRNewswire-FirstCall/ -- Abbott today announced that the U.S. Food a...FDA Approves ACIPHEX(R) (rabeprazole sodium) 20 mg for Short-Term Treatment of GERD in Adolescents
WOODCLIFF LAKE, N.J., June 30 /PRNewswire/ -- Eisai Corporation of North America, a wholly-owned subsidiary of Tokyo-based Eisai Co., Ltd., announced today that the Food and Drug Administration (FDA) has approved ACIPHEX (rabeprazole sodium) 20 mg for the short-term (up to eight weeks) treatme...Big Win for Biodiesel: ASTM Approves New Biodiesel Blend Specifications
Automakers, Fleets Encouraged by New Biodiesel Standards VANCOUVER, British Columbia, June 20 /PRNewswire/ -- The biodiesel industry is celebrating today following last night's final vote by the ASTM International D02 Main Committee to approve a trio of long-awaited ASTM specifications...